William J. Burnett

No ORCID on file · 1 paper in corpus
2022
·doi:10.1101/2022.08.15.504039

ABSTRACT Aberrant activation of the PI3K-AKT pathway is common in melanoma but efforts to drug this pathway have proven largely ineffective in patients. In this study, we observed that pharmacological inhibition of AKT was ineffective wher…